ScoreWhy is Marksans Pharma Ltd ?
1
Poor long term growth as Operating profit has grown by an annual rate 12.98% of over the last 5 years
2
Flat results in Sep 25
- ROCE(HY) Lowest at 16.13%
- INVENTORY TURNOVER RATIO(HY) Lowest at 2.86 times
3
With ROE of 13.1, it has a Expensive valuation with a 3.2 Price to Book Value
- The stock is trading at a fair value compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -46.78%, its profits have risen by 1.4% ; the PEG ratio of the company is 17.9
4
Underperformed the market in the last 1 year
- Even though the market (BSE500) has generated returns of 2.07% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -46.78% returns
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Marksans Pharma for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Marksans Pharma
-46.88%
-1.04
45.02%
Sensex
4.85%
0.41
11.83%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
15.81%
EBIT Growth (5y)
12.98%
EBIT to Interest (avg)
32.48
Debt to EBITDA (avg)
0.35
Net Debt to Equity (avg)
-0.12
Sales to Capital Employed (avg)
1.13
Tax Ratio
24.75%
Dividend Payout Ratio
8.67%
Pledged Shares
0
Institutional Holding
22.20%
ROCE (avg)
27.77%
ROE (avg)
16.65%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
24
Industry P/E
34
Price to Book Value
3.16
EV to EBIT
19.55
EV to EBITDA
15.97
EV to Capital Employed
3.46
EV to Sales
2.98
PEG Ratio
17.89
Dividend Yield
0.43%
ROCE (Latest)
17.72%
ROE (Latest)
13.08%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend1What is working for the Company
NET SALES(Q)
Highest at Rs 720.41 cr
-4What is not working for the Company
ROCE(HY)
Lowest at 16.13%
INVENTORY TURNOVER RATIO(HY)
Lowest at 2.86 times
Loading Valuation Snapshot...
Here's what is working for Marksans Pharma
Net Sales - Quarterly
Highest at Rs 720.41 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Here's what is not working for Marksans Pharma
Inventory Turnover Ratio- Half Yearly
Lowest at 2.86 times and Fallen
each half year in the last five half yearly periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
